References
Aguilar-Parada, E., Eisentraut, A. M. and Unger, R. H. 1969. Pancreatic glucagon secretion in normal and diabetic subjects. Amer. J. Med. Sci., 257, 415.
Alford, F. P., Bloom, S. R., Nabarro, J. D. N., Hall, R., Besser, G. M., Coy, D. H., Kastrin, A. J. and Schally, A. V. 1974. Glucagon control of fasting glucose in man. Lancet, ii, 974.
Ardill, J., Montgomery, D. A. D. and Hadden, D. R. 1974. Gastrin in diabetes. Diabetologia, 10, 357.
Brazeau, P., Vale, W., Burgus, N., Ling, N., Butcher, M., Rivier, J. and Guillemin, R. 1973. Hypothalamic polypeptide that inhibits the secretion of immunoreactive growth hormone, Science (Washington, D.C.), 179, 77.
Buchanan, K. D., Flanagan, R. W. J., Murphy, R. F., O’Connor, F. A. and Shahidullah, M. 1974. Immunological characterisation of glucagon-like immunoreactivity. Europ. J. Clin. Invest., 4, 326.
Buchanan, K. D. and Mawhinne, W. A. A. 1973a. Glucagon release from isolated pancreas in streptozotocin-treated rats. Diabetes, 22, 797.
Buchanan, K. D. and Mawhinney, W. A. A. 1973b. Insulin control of glucagon release from insulin-deficient rat islets. Diabetes, 22, 801.
Chisholm, D. J., Young, J. D. and Lazarus, L. 1969. The gastrointestinal stimulus to insulin release. 1. secretin. J. Clin. Invest., 48, 1453.
Conlon, J. M., Flanagan, R. W. J. and Murphy, R. F. 1975. An improved affinity chromatographic system for the purification of glucagon-like immunoreactivity (G.L.I.). Diabetologia, 11, 336.
Flanagan, R. W. J., Buchanan, K. D. and Murphy, R. F. 1974. Specificity of antibodies in radioimmunoassay of glucagon. Diabetologia, 10, 365.
Flanagan, R. W. J., Trimble, E. R., Conlon, J. M. and Murphy, R. F. 1975. Purification and characterisation of plasma glucagon-like immunoreactivity by immunoaffinity chromatography. Diabetologia, 11, 342.
Gerich, J. E., Lorenzi, M., Schneider, V., Karam, J. H., Rivier, J., Guillemin, R. and Forsham, P. H. 1974. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. New Eng. J. Med., 291, 544.
Hadden, D. R., Montgomery, D. A. D., Skelly, R. J., Trimble, E. R., Weaver, J. A., Wilson, E. A. and Buchanan, K. D. 1975. Maturity onset diabetes mellitus: response to intensive dietary management. Brit. Med. J., iii, 276.
Hayes, J. R., Ardill, J. and Buchanan, K. D. 1975. Gastrin and insulin release. Diabetologia, 11, 89.
Henry, R. W., Flanagan, R. W. J. and Buchanan, K. D. 1975. Secretin: a new role for an old hormone. Lancet, ii, 202.
Henry, R. W., Ardill, J. and Buchanan K. D. 1975. Pancreatic and gut hormones in starvation diabetes. Diabetologia, 11, 349.
Lazarus, N. R., Voyles, N. R., Devrim, S., Tanese, T. and Recant, L. 1968. Extra-gastrointestinal effects of secretin, gastrin and pancreozymin. Lancet, ii, 248.
McIntyre, M., Holdsworth, C. D. and Turner, D. S. 1965. Intestinal factors in the control of insulin secretion. J. Clin Endocrinol., 25, 1317.
Mallinson, C. N., Bloom, S. R., Warin, A. O., Salmon, P. R. and Cox, B. 1974. A glucagonoma syndrome. Lancet, ii, 1.
Muller, W. A., Faloona, G. R. and Unger, R. H. 1973. Hyperlucagonaemia in diabetic ketoacidosis. Its prevalence and significance. Amer. J. Med., 54, 52.
Murphy, R. F., Buchanan, K. D. and Elmore, D. T. 1973. Isolation of glucagon-like immunoreactivity of gut by affinity chromatography on anti-glucagon antibodies coupled to Sepharose 4B. Biochim. Biophys. Acta, 303, 118.
O’Connor, F. A., Connon, J. J., Buchanan, K. D. and Shahidullah, M. 1976. Secretin and insulin: response to intraduodenal acid. Diabetologia (in press).
Ross, S. A., Brown, J. C. and Dupre, J. 1974. Effect of gastric inhibitory polypeptide on endocrine pancreas in normal and diabetic subjects. Diabetologia, 10, 384.
Samols, E., Marri, G. and Marks, V. 1965. Promotion of insulin secretion by glucagon. Lancet, ii, 415.
Trimble, E. R., Montgomery, D. A. D. and Hadden, D. R. 1974. Change in pattern of glucagon response during OGTT before and six months after commencement of intensive dietary management of diabetes. Diabetologia, 10, 389.
Trimble, E. R., Buchanan, K. D., Hadden, D. R., Montgomery, D. A. D. and Weaver, J. A. 1975. Hypersecretinaemia in maturity onset diabetes correctable by dietary measures. Diabetologia, 11, 380.
Unger, R. H., Eisentraut, A. M., McCall, M. S. and Madison, L. L. 1961. Glucagon antibodies and an immunoassay for glucagon. J. Clin. Invest., 40, 1280.
Unger, R. H., Ketterer, H., Dupre, J. and Eisentraut, A. M. 1967. The effects of secretin, pancreozymin and gastrin on insulin and glucagon secretion in anaesthetised dogs. J. Clin. Invest. 46, 630.
Williams, R. H. 1974. Text Book of Endocrinology, 5th edition, W. B. Saunders, Philadelphia, p. 542.
Wise, J. K., Hendler, R. and Felig, P. 1973. Evaluation of alpha cell function by infusion of alanine in normal, diabetic and obese subjects. New Eng. J. Med., 288, 487.
Yalow, R. S. and Berson, S. A. 1961. Immunoassay of plasma insulin in man. Diabetes, 10, 339.
Author information
Authors and Affiliations
Additional information
The Graves Lecture, 1975.
Rights and permissions
About this article
Cite this article
Buchanan, K.D. The gut as an endocrine organ. IJMS 145, 103–115 (1976). https://doi.org/10.1007/BF02938929
Issue Date:
DOI: https://doi.org/10.1007/BF02938929